Vaccine series completion for rotavirus, DTaP, PCV at 12 months was highest in January 2020 and remained lower in October 2023.

Multiple vaccine-related petitions that have been filed before courts reflect growing concerns about how vaccines are ...

The US Vaccines Market, (excluding COVID-19 vaccines), valued at US$25.98 billion in 2024, is forecasted to grow at a robust ...

Rotavirus is a gastrointestinal infection that mostly affects children under age 5. There are now rotavirus vaccines that have kept many kids healthy. For those who do get infected, rotavirus can ...

Covid boosters are available to book from today. Some 7.5 million in England are eligible, including adults aged 75 years and over, residents in care homes and people with a weakened immune ...

Researchers uncover how probiotics and diet shape the gut microbiome to boost vaccine efficacy, offering new avenues for ...

Can the continent walk the talk? **** The African Union has embarked on one of its most audacious health security missions: ...

As donor support dwindles ahead of 2029, Gavi, the Vaccine Alliance has formally reminded the government to fulfill its ...

Amezosvatein has shown excellent immunogenicity and improved tolerability in Phase 2 study -- Medicxi leads round, joined by ...

Children are most likely to get rotavirus disease in the winter and spring; it tends to start in the Southwest in December and move to the Northeast by April to May, though kids c ...

Local vaccine production aims to empower Egypt as a critical player in the fight against preventable diseases in Africa and beyond.

Batavia Biosciences has partnered with Vaccine Biotechnology City and MEVAC to enhance local vaccine manufacturing capabilities in Egypt.